JOANNA JANKOWSKY to Animals
This is a "connection" page, showing publications JOANNA JANKOWSKY has written about Animals.
Connection Strength
0.859
-
TMEM106B coding variant is protective and deletion detrimental in a mouse model of tauopathy. Acta Neuropathol. 2024 Mar 25; 147(1):61.
Score: 0.042
-
Doxycycline for transgene control disrupts gut microbiome diversity without compromising acute neuroinflammatory response. J Neuroinflammation. 2024 Jan 04; 21(1):11.
Score: 0.042
-
Activity disruption causes degeneration of entorhinal neurons in a mouse model of Alzheimer's circuit dysfunction. Elife. 2022 12 05; 11.
Score: 0.039
-
Temporal and spatially controlled APP transgene expression using Cre-dependent alleles. Dis Model Mech. 2022 05 01; 15(5).
Score: 0.037
-
Gene therapy using A? variants for amyloid reduction. Mol Ther. 2021 07 07; 29(7):2294-2307.
Score: 0.034
-
Cross-species genetic screens to identify kinase targets for APP reduction in Alzheimer's disease. Hum Mol Genet. 2019 06 15; 28(12):2014-2029.
Score: 0.030
-
Combination anti-A? treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice. J Exp Med. 2018 05 07; 215(5):1349-1364.
Score: 0.028
-
Practical considerations for choosing a mouse model of Alzheimer's disease. Mol Neurodegener. 2017 12 22; 12(1):89.
Score: 0.027
-
Discrete Pools of Oligomeric Amyloid-? Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis. Am J Pathol. 2018 03; 188(3):739-756.
Score: 0.027
-
Neuronal overexpression of human VAPB slows motor impairment and neuromuscular denervation in a mouse model of ALS. Hum Mol Genet. 2016 11 01; 25(21):4661-4673.
Score: 0.025
-
Impaired Recall of Positional Memory following Chemogenetic Disruption of Place Field Stability. Cell Rep. 2016 07 19; 16(3):793-804.
Score: 0.025
-
Humanized Tau Mice with Regionalized Amyloid Exhibit Behavioral Deficits but No Pathological Interaction. PLoS One. 2016; 11(4):e0153724.
Score: 0.024
-
Widespread Neuronal Transduction of the Rodent CNS via Neonatal Viral Injection. Methods Mol Biol. 2016; 1382:239-50.
Score: 0.024
-
Transgene expression in the Nop-tTA driver line is not inherently restricted to the entorhinal cortex. Brain Struct Funct. 2016 05; 221(4):2231-49.
Score: 0.023
-
Intracerebroventricular viral injection of the neonatal mouse brain for persistent and widespread neuronal transduction. J Vis Exp. 2014 Sep 15; (91):51863.
Score: 0.022
-
Impairments in experience-dependent scaling and stability of hippocampal place fields limit spatial learning in a mouse model of Alzheimer's disease. Hippocampus. 2014 Aug; 24(8):963-78.
Score: 0.021
-
Specificity and efficiency of reporter expression in adult neural progenitors vary substantially among nestin-CreER(T2) lines. J Comp Neurol. 2014 Apr 01; 522(5):1191-208.
Score: 0.021
-
Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J Neurosci. 2014 Mar 12; 34(11):3826-40.
Score: 0.021
-
Wild-type neural progenitors divide and differentiate normally in an amyloid-rich environment. J Neurosci. 2013 Oct 30; 33(44):17335-41.
Score: 0.021
-
Viral transduction of the neonatal brain delivers controllable genetic mosaicism for visualising and manipulating neuronal circuits in vivo. Eur J Neurosci. 2013 Apr; 37(8):1203-20.
Score: 0.019
-
Strain background influences neurotoxicity and behavioral abnormalities in mice expressing the tetracycline transactivator. J Neurosci. 2012 Aug 01; 32(31):10574-86.
Score: 0.019
-
Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult. Mol Neurodegener. 2012 Jun 18; 7:28.
Score: 0.019
-
Robust amyloid clearance in a mouse model of Alzheimer's disease provides novel insights into the mechanism of amyloid-beta immunotherapy. J Neurosci. 2011 Mar 16; 31(11):4124-36.
Score: 0.017
-
Remote sites of structural atrophy predict later amyloid formation in a mouse model of Alzheimer's disease. Neuroimage. 2010 Apr 01; 50(2):416-27.
Score: 0.016
-
Alzheimer's-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci. 2007 Jun 20; 27(25):6771-80.
Score: 0.013
-
Rodent A beta modulates the solubility and distribution of amyloid deposits in transgenic mice. J Biol Chem. 2007 Aug 03; 282(31):22707-20.
Score: 0.013
-
Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med. 2005 Dec; 2(12):e355.
Score: 0.012
-
Environmental enrichment mitigates cognitive deficits in a mouse model of Alzheimer's disease. J Neurosci. 2005 May 25; 25(21):5217-24.
Score: 0.011
-
APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging. 2004 Aug; 25(7):885-92.
Score: 0.011
-
Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol. 2003 Dec; 62(12):1220-7.
Score: 0.010
-
Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum Mol Genet. 2004 Jan 15; 13(2):159-70.
Score: 0.010
-
An automated respiratory data pipeline for waveform characteristic analysis. J Physiol. 2023 11; 601(21):4767-4806.
Score: 0.010
-
TMEM106B regulates microglial proliferation and survival in response to demyelination. Sci Adv. 2023 05 05; 9(18):eadd2676.
Score: 0.010
-
Transgenic mouse models of neurodegenerative disease: opportunities for therapeutic development. Curr Neurol Neurosci Rep. 2002 Sep; 2(5):457-64.
Score: 0.009
-
Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng. 2001 Jun; 17(6):157-65.
Score: 0.009
-
The role of cytokines and growth factors in seizures and their sequelae. Prog Neurobiol. 2001 Feb; 63(2):125-49.
Score: 0.008
-
Cytokine responses to LTP induction in the rat hippocampus: a comparison of in vitro and in vivo techniques. Learn Mem. 2000 Nov-Dec; 7(6):400-12.
Score: 0.008
-
Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease. J Clin Invest. 2020 04 01; 130(4):1912-1930.
Score: 0.008
-
Cytokine and growth factor involvement in long-term potentiation. Mol Cell Neurosci. 1999 Dec; 14(6):273-86.
Score: 0.008
-
Differential regulation of cytokine expression following pilocarpine-induced seizure. Exp Neurol. 1999 Oct; 159(2):333-46.
Score: 0.008
-
Cytokine and growth factor involvement in long-term potentiation. Mol Cell Neurosci. 1999 Oct-Nov; 14(4-5):273-86.
Score: 0.008
-
Brain-wide distribution of reporter expression in five transgenic tetracycline-transactivator mouse lines. Sci Data. 2019 02 26; 6:190028.
Score: 0.007
-
Combination of A? Suppression and Innate Immune Activation in the Brain Significantly Attenuates Amyloid Plaque Deposition. Am J Pathol. 2017 Dec; 187(12):2886-2894.
Score: 0.007
-
Amyloid-? plaques disrupt axon initial segments. Exp Neurol. 2016 07; 281:93-8.
Score: 0.006
-
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease. J Neurosci. 2016 Jan 13; 36(2):577-89.
Score: 0.006
-
Quaternary Structure Defines a Large Class of Amyloid-? Oligomers Neutralized by Sequestration. Cell Rep. 2015 Jun 23; 11(11):1760-71.
Score: 0.006
-
Wild-type microglia do not reverse pathology in mouse models of Rett syndrome. Nature. 2015 May 21; 521(7552):E1-4.
Score: 0.006
-
NF?B-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease. Neuron. 2015 Jan 07; 85(1):101-115.
Score: 0.006
-
Cerebral vascular leak in a mouse model of amyloid neuropathology. J Cereb Blood Flow Metab. 2014 Oct; 34(10):1646-54.
Score: 0.005
-
Genetic modulation of soluble A? rescues cognitive and synaptic impairment in a mouse model of Alzheimer's disease. J Neurosci. 2014 Jun 04; 34(23):7871-85.
Score: 0.005
-
Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS One. 2013; 8(6):e67680.
Score: 0.005
-
Neuronal aggregates are associated with phenotypic onset in the R6/2 Huntington's disease transgenic mouse. Behav Brain Res. 2012 Apr 15; 229(2):308-19.
Score: 0.005
-
GABA transporter function, oligomerization state, and anchoring: correlates with subcellularly resolved FRET. J Gen Physiol. 2009 Dec; 134(6):489-521.
Score: 0.004
-
Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice. Hum Mol Genet. 2001 Oct 15; 10(22):2525-37.
Score: 0.002